Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,193
Price
$104.27
Total Value
$228.66K
Shares Held After
66,504
% of Holdings
3.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,500
Price
$180.36
Total Value
$450.89K
Shares Held After
177,634
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
291
Price
$183.08
Total Value
$53.28K
Shares Held After
93,800
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,909
Price
$182.58
Total Value
$348.54K
Shares Held After
94,091
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$181.40
Total Value
$362.79K
Shares Held After
96,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$180.35
Total Value
$360.69K
Shares Held After
98,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chen Wan-Shan — Director
Shares
1,100
Price
$180.43
Total Value
$198.47K
Shares Held After
9,096
% of Holdings
10.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.41
Total Value
$14.10K
Shares Held After
13,586,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,576,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,566,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,000
Price
$1.43
Total Value
$7.15K
Shares Held After
13,556,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,551,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,240
Price
$1.43
Total Value
$7.49K
Shares Held After
13,541,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,536,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
20,000
Price
$1.43
Total Value
$28.60K
Shares Held After
13,526,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
4,760
Price
$1.44
Total Value
$6.85K
Shares Held After
13,506,650
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.44
Total Value
$14.40K
Shares Held After
13,501,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
500,000
Price
$1.44
Total Value
$720.00K
Shares Held After
13,491,890
% of Holdings
3.7%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
105,000
Price
$1.46
Total Value
$153.30K
Shares Held After
12,991,890
% of Holdings
0.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
14,500
Price
$3.38
Total Value
$49.01K
Shares Held After
518,622
% of Holdings
2.7%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
135,201
Price
$16.59
Total Value
$2.24M
Shares Held After
3,936,436
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
162
Price
$582.30
Total Value
$94.33K
Shares Held After
18,876
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,756
Price
$580.64
Total Value
$1.02M
Shares Held After
19,038
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,224
Price
$579.75
Total Value
$709.61K
Shares Held After
20,794
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,139
Price
$578.52
Total Value
$658.94K
Shares Held After
22,018
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,617
Price
$577.77
Total Value
$934.25K
Shares Held After
23,157
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,586
Price
$576.63
Total Value
$914.53K
Shares Held After
24,774
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,956
Price
$575.53
Total Value
$1.13M
Shares Held After
26,360
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$574.87
Total Value
$321.93K
Shares Held After
28,316
% of Holdings
1.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
8,224
Price
$89.84
Total Value
$738.84K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$89.00
Total Value
$222.50K
Shares Held After
53,542
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,670
Price
$87.11
Total Value
$232.59K
Shares Held After
56,042
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,094
Price
$86.62
Total Value
$268.00K
Shares Held After
58,712
% of Holdings
5.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
109,767
Price
$6.40
Total Value
$702.18K
Shares Held After
316,483
% of Holdings
25.8%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Monte Rosa Therapeutics, Inc. (GLUE)
Nickson Philip — Chief Business & Legal Officer
Shares
5,845
Price
$17.69
Total Value
$103.41K
Shares Held After
55,000
% of Holdings
9.6%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.53
Total Value
$7.89K
Shares Held After
729,123
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
38
Price
$581.45
Total Value
$22.10K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,482
Price
$580.84
Total Value
$860.81K
Shares Held After
40,551
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,046
Price
$580.07
Total Value
$606.75K
Shares Held After
42,033
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,140
Price
$578.83
Total Value
$659.86K
Shares Held After
43,079
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$577.90
Total Value
$1.05M
Shares Held After
44,219
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,478
Price
$576.69
Total Value
$852.35K
Shares Held After
46,034
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$575.75
Total Value
$714.51K
Shares Held After
47,512
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$575.04
Total Value
$724.54K
Shares Held After
48,753
% of Holdings
2.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
200
Price
$28.41
Total Value
$5.68K
Shares Held After
142,084
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
23,133
Price
$27.74
Total Value
$641.60K
Shares Held After
142,284
% of Holdings
14.0%
Showing 401–450 of 1153 transactions (page 9 of 24)